CHD4 anticorps

N° du produit ABIN6972352

Détail du produit anti-CHD4 anticorps

Antigène: CHD4 (Chromodomain Helicase DNA Binding Protein 4 (CHD4))

Reactivité: Humain, Souris

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CHD4 est non-conjugé

Application: Western Blotting (WB)

Attributs du produit: Mi-2b (Mi-2beta, CHD4, chromodomain helicase DNA-binding protein 4) represents the major Mi-2 isoform present in the complex Mi-2/NuRD. This complex is a multi-subunit protein complex containing both histone deacetylase and nucleosome-dependent ATPase subunits. Current models predict that this complex functions primarily in transcriptional repression. In addition to the ATPase domain, Mi-2 beta contains a chromodomain and two PHD domains. Mi-2 beta interacts with BRG-1, a component of the SWI/SNF complex, and the RET finger protein (RFP). Mi-2 beta antibody (mAb) (Clone 3F2/4) was raised in a Mouse host. It has been validated for use in Western blot, it has been shown to react with Human and Mouse samples.

Purification: Protein G Chromatography

Immunogène: This Mi-2 beta antibody was raised against a synthetic peptide derived from human Mi-2B.

Clone: 3F2-4

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Purified IgG in 70 mM Tris ( pH 8), 105 mM NaCl, 31 mM glycine, 0.07 mM EDTA, 30 % glycerol and 0.035 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.

Détails sur CHD4

Antigène: CHD4 (Chromodomain Helicase DNA Binding Protein 4 (CHD4))

Autre désignation: Mi-2 beta (CHD4 Produits)

Poids moléculaire: 240 kDa

NCBI Accession: NP_001264